Global Mycoplasma Testing in Clinical Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Mycoplasma Testing in Clinical Market Overview

• 1.1 Product Overview and Scope of Mycoplasma Testing in Clinical
• 1.2 Classification of Mycoplasma Testing in Clinical by Types
  • 1.2.1 Global Mycoplasma Testing in Clinical Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Mycoplasma Testing in Clinical Revenue Market Share by Types in 2018
  • 1.2.3 PCR
  • 1.2.4 ELSA
  • 1.2.5 Enzymatic Methods
  • 1.2.6 DNA Staining
• 1.3 Global Mycoplasma Testing in Clinical Market by Application
  • 1.3.1 Global Mycoplasma Testing in Clinical Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Cell Line Testing
  • 1.3.3 Virus Testing
  • 1.3.4 Others
• 1.4 Global Mycoplasma Testing in Clinical Market by Regions
  • 1.4.1 Global Mycoplasma Testing in Clinical Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Mycoplasma Testing in Clinical Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Mycoplasma Testing in Clinical Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Mycoplasma Testing in Clinical Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Mycoplasma Testing in Clinical Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Mycoplasma Testing in Clinical Status and Prospect (2014-2024)
• 1.5 Global Market Size of Mycoplasma Testing in Clinical (2014-2024)

2 Company Profiles

• 2.1 Sartorius AG
  • 2.1.1 Business Overview
  • 2.1.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Sartorius AG Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Clongen Laboratories
  • 2.2.1 Business Overview
  • 2.2.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Clongen Laboratories Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Bio-Rad Laboratories, Inc.
  • 2.3.1 Business Overview
  • 2.3.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Bio-Rad Laboratories, Inc. Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 MERCK KGAA
  • 2.4.1 Business Overview
  • 2.4.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 MERCK KGAA Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Charles River
  • 2.5.1 Business Overview
  • 2.5.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Charles River Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 ELITechGROUP
  • 2.6.1 Business Overview
  • 2.6.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 ELITechGROUP Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 PromoCell GmbH
  • 2.7.1 Business Overview
  • 2.7.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 PromoCell GmbH Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Minerva Biolabs
  • 2.8.1 Business Overview
  • 2.8.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Minerva Biolabs Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Eurofins Scientific
  • 2.9.1 Business Overview
  • 2.9.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Eurofins Scientific Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 BioFire Diagnostics
  • 2.10.1 Business Overview
  • 2.10.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 BioFire Diagnostics Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 ZEAKON Diagnostics
  • 2.11.1 Business Overview
  • 2.11.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 ZEAKON Diagnostics Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Lonza
  • 2.12.1 Business Overview
  • 2.12.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Lonza Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Liofilchem Srl
  • 2.13.1 Business Overview
  • 2.13.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Liofilchem Srl Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Roche
  • 2.14.1 Business Overview
  • 2.14.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Roche Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Agilent Technologies, Inc.
  • 2.15.1 Business Overview
  • 2.15.2 Mycoplasma Testing in Clinical Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Agilent Technologies, Inc. Mycoplasma Testing in Clinical Revenue, Gross Margin and Market Share (2017-2018)

3 Global Mycoplasma Testing in Clinical Market Competition, by Players

• 3.1 Global Mycoplasma Testing in Clinical Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Mycoplasma Testing in Clinical Players Market Share
  • 3.2.2 Top 10 Mycoplasma Testing in Clinical Players Market Share
• 3.3 Market Competition Trend

4 Global Mycoplasma Testing in Clinical Market Size by Regions

• 4.1 Global Mycoplasma Testing in Clinical Revenue and Market Share by Regions
• 4.2 North America Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 4.3 Europe Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 4.5 South America Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)

5 North America Mycoplasma Testing in Clinical Revenue by Countries

• 5.1 North America Mycoplasma Testing in Clinical Revenue by Countries (2014-2019)
• 5.2 USA Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 5.3 Canada Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)

6 Europe Mycoplasma Testing in Clinical Revenue by Countries

• 6.1 Europe Mycoplasma Testing in Clinical Revenue by Countries (2014-2019)
• 6.2 Germany Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 6.3 UK Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 6.4 France Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 6.5 Russia Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 6.6 Italy Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Mycoplasma Testing in Clinical Revenue by Countries

• 7.1 Asia-Pacific Mycoplasma Testing in Clinical Revenue by Countries (2014-2019)
• 7.2 China Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 7.3 Japan Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 7.4 Korea Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 7.5 India Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)

8 South America Mycoplasma Testing in Clinical Revenue by Countries

• 8.1 South America Mycoplasma Testing in Clinical Revenue by Countries (2014-2019)
• 8.2 Brazil Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Mycoplasma Testing in Clinical by Countries

• 9.1 Middle East and Africa Mycoplasma Testing in Clinical Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 9.3 UAE Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Mycoplasma Testing in Clinical Revenue and Growth Rate (2014-2019)

10 Global Mycoplasma Testing in Clinical Market Segment by Type

• 10.1 Global Mycoplasma Testing in Clinical Revenue and Market Share by Type (2014-2019)
• 10.2 Global Mycoplasma Testing in Clinical Market Forecast by Type (2019-2024)
• 10.3 PCR Revenue Growth Rate (2014-2024)
• 10.4 ELSA Revenue Growth Rate (2014-2024)
• 10.5 Enzymatic Methods Revenue Growth Rate (2014-2024)
• 10.6 DNA Staining Revenue Growth Rate (2014-2024)

11 Global Mycoplasma Testing in Clinical Market Segment by Application

• 11.1 Global Mycoplasma Testing in Clinical Revenue Market Share by Application (2014-2019)
• 11.2 Mycoplasma Testing in Clinical Market Forecast by Application (2019-2024)
• 11.3 Cell Line Testing Revenue Growth (2014-2019)
• 11.4 Virus Testing Revenue Growth (2014-2019)
• 11.5 Others Revenue Growth (2014-2019)

12 Global Mycoplasma Testing in Clinical Market Size Forecast (2019-2024)

• 12.1 Global Mycoplasma Testing in Clinical Market Size Forecast (2019-2024)
• 12.2 Global Mycoplasma Testing in Clinical Market Forecast by Regions (2019-2024)
• 12.3 North America Mycoplasma Testing in Clinical Revenue Market Forecast (2019-2024)
• 12.4 Europe Mycoplasma Testing in Clinical Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Mycoplasma Testing in Clinical Revenue Market Forecast (2019-2024)
• 12.6 South America Mycoplasma Testing in Clinical Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Mycoplasma Testing in Clinical Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology